Meridian Bioscience Inc.

NASDAQ:VIVO   3:59:34 PM EDT
17.99
-0.62 (-3.33%)
Products

Meridian Bioscience Submits Application To FDA For Emergency Use Authorization For SARS-CoV-2 Molecular Assay

Published: 12/08/2020 20:29 GMT
Meridian Bioscience Inc. (VIVO) - Meridian Bioscience Submits Application to FDA for Emergency Use Authorization for Sars-cov-2 Molecular Assay.